[Thrombolytic treatment in stroke in patients with intracardiac thrombus: presentation of one case].
Intravenous tissue plasminogen activator (t-PA) is a recent proven effective treatment for acute ischemic stroke patients. However, the use of t-PA in some special settings is controversial. One of these is the presence of a cardiac thrombus, given that the use of t-PA could potentially accelerate breakup of the thrombus and cause additional embolisms. The authors describe the case of a cardiological patient with a cardiac thrombus who was given IV t-PA for acute stroke treatment without complications. We discuss the necessity or not of a 24 hours delay before anticoagulants administration in these special patients.
Segura
T
T
Sección de Neurología, Hospital General Universitario de Albacete, Hermanos Falcó, s/n, 02006 Albacete, Spain. tseguram@meditex.es
Herrera
M
M
Garcia-Muñozguren
S
S
Zorita
M D
MD
D020520:Brain Infarction / Q000150:complications* / Q000188:drug therapy; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000150:complications* / Q000188:drug therapy*; D013927:Thrombosis / Q000150:complications*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D010959:Tissue Plasminogen Activator